View Author
scopus: 7005680302

Jonkers, J.

(Jos Jonkers)


cancer tumor mouse 2-deficient chromosome brca 2-deficient tumor cell lines tumours mutation model brca 2 inhibition repair growth analysis study inhibitor tumor cells genomic breast control result clonal cell lines metastase azd 2281 cisplatin recombination brca 2-deficient cells pten ko mice ic 50 values kb 2p lines mouse model cell lines clonal allele copyright 2-proficient john wiley growth inhibition combination gland agent netherland pheochromocytoma hybridization cancer research www.aacrjournals.org prostate lung metastases pathol rad 51 article brca 1 parp inhibitors cancer research research sensitivity psa-cre value damage alteration month kb 2p cells brca 2 expression 37 ◦ c ko mice american brca 2-proficient cells pathogenesis aberration mouse models dna damage association methylmethane sulfonate absence brca 2f alleles region array temozolomide antibody downloaded




2 Most Recent Publications

Conditional Pten knock-out mice: A model for metastatic phaeochromocytoma (Article)
Korpershoek, E. Loonen, A.J.M. Krijger, R.R. de Corvers, S. Nederveen, F.H. van Jonkers, J. Ma, X. Made, A.Z. van der Korsten, H. Trapman, J. Dinjens, W.N.M.
2009-03-01
Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin (Article)
Evers, B. Drost, R. Smith, G.C.M. Martin, N.M.B. Lau, A. O'Connor, M.J. Jonkers, J. Schut, F.T. Bruin, M. de Burg, E.D. van Derksen, P.W.B. Holstege, H. Liu, X. Drunen, E. van Beverloo, H.B.
2008-06-15